Physician profile
Barry Luskey
NPI 1548274004
$16,364.07
in general payments reported to CMS, 2019-2025
72 companies · $2,726 in 2025
The $2,726 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,617 · 2020: $681 · 2021: $1,751 · 2022: $2,979 · 2023: $2,144 · 2024: $3,466 · 2025: $2,726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,544 · Education: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,543.94 |
| Education | $791.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,329.51 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Novartis Pharmaceuticals Corporation | $1,086.80 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $825.65 | 2019-2025 | Calquence, Lynparza, Imfinzi |
| Astellas Pharma US INC | $735.72 | 2019-2025 | Xtandi, Padcev, Xospata |
| E.R. Squibb & Sons, L.L.C. | $724.15 | 2019-2025 | Opdivo, Opdualag, Krazati |
| Janssen Biotech, INC. | $723.89 | 2019-2025 | Darzalex, Tecvayli, Talvey |
| Amgen INC. | $679.57 | 2019-2023 | Kyprolis, Blincyto, Nplate |
| Daiichi Sankyo INC. | $666.29 | 2019-2025 | Enhertu, Injectafer, Vanflyta |
| Pfizer INC. | $634.60 | 2019-2025 | |
| Celgene Corporation | $614.38 | 2019-2025 | Pomalyst, Reblozyl, Opdualag |
| Seagen INC. | $574.01 | 2019-2025 | Adcetris, Padcev |
| Genzyme Corporation | $476.43 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $429.02 | 2021-2025 | Libtayo |
| Genentech USA, INC. | $398.51 | 2019-2025 | Lunsumio, Polivy, Columvi |
| Gilead Sciences, INC. | $375.84 | 2021-2025 | Trodelvy |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $362.47 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Incyte Corporation | $345.71 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Acrotech Biopharma INC. | $323.25 | 2021-2025 | Beleodaq |
| Takeda Pharmaceuticals U.S.A., INC. | $314.64 | 2019-2025 | Iclusig, Ninlaro, Fruzaqla |
| Bayer Healthcare Pharmaceuticals INC. | $283.68 | 2019-2025 | |
| Eisai INC. | $268.21 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $254.13 | 2019-2022 | |
| Rigel Pharmaceuticals, INC. | $238.50 | 2021-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Exelixis INC. | $233.75 | 2019-2025 | Cabometyx |
| Abbvie INC. | $230.83 | 2019-2025 | |
| Global Blood Therapeutics, INC. | $201.16 | 2020-2022 | |
| Puma Biotechnology, INC. | $200.65 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $200.36 | 2019-2025 | Onivyde, Somatuline Depot |
| Kite Pharma, INC. | $198.83 | 2021-2025 | Yescarta |
| Glaxosmithkline, LLC. | $178.02 | 2021-2025 | Ojjaara, Zejula, Jemperli |
| Taiho Oncology, INC. | $141.08 | 2019-2025 | |
| Array Biopharma INC | $131.87 | 2021-2025 | Lorbrena, Braftovi, Mektovi |
| Jazz Pharmaceuticals INC. | $129.21 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.03 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $117.96 | 2021-2024 | Ultomiris |
| Karyopharm Therapeutics INC. | $114.74 | 2022-2025 | Xpovio |
| Beigene USA, INC. | $105.69 | 2022-2025 | Brukinsa |
| Sobi, INC | $97.82 | 2024-2025 | |
| G1 Therapeutics, INC. | $94.50 | 2022-2023 | Cosela |
| Tersera Therapeutics LLC | $93.24 | 2021-2022 | |
| Adaptive Biotechnologies Corporation | $89.69 | 2022-2025 | Clonoseq |
| Cti Biopharma Corp. | $70.70 | 2023 | Vonjo |
| Stemline Therapeutics INC. | $67.92 | 2022-2025 | Orserdu |
| Pharmacosmos Therapeutics INC. | $61.39 | 2022-2024 | Cosela |
| Beone Medicines USA, INC. | $60.00 | 2025 | Brukinsa |
| Aveo Pharmaceuticals, INC. | $50.88 | 2022-2024 | Fotivda |
| Mylan Institutional INC. | $49.33 | 2021-2022 | |
| Servier Pharmaceuticals LLC | $48.44 | 2022-2024 | |
| Alnylam Pharmaceuticals INC. | $46.13 | 2024 | Givlaari |
| Adc Therapeutics America, INC. | $46.00 | 2024-2025 | |
| Emd Serono, INC. | $38.77 | 2019-2024 | |
| Pharmacyclics LLC, An Abbvie Company | $36.01 | 2019-2020 | |
| Clovis Oncology, INC. | $34.54 | 2019-2022 | |
| Deciphera Pharmaceuticals INC. | $32.45 | 2021-2025 | Romvimza, Qinlock |
| Springworks Therapeutics, INC. | $31.86 | 2024-2025 | Ogsiveo |
| Shire North American Group INC | $28.24 | 2019 | |
| Morphosys, US INC. | $27.91 | 2022-2023 | Monjuvi |
| Apellis Pharmaceuticals, INC. | $25.14 | 2025 | Empaveli |
| Csl Behring | $24.69 | 2022 | |
| Heron Therapeutics, INC. | $24.29 | 2019 | |
| Geron Corporation | $24.21 | 2025 | Rytelo |
| Azurity Pharmaceuticals, INC. | $22.53 | 2025 | Danziten |
| Epizyme, INC. | $22.31 | 2022 | |
| Amag Pharmaceuticals, INC. | $19.47 | 2021 | |
| Octapharma USA, INC. | $18.60 | 2023 | Octagam Immune Globulin (Human) |
| Kyowa Kirin, INC. | $17.84 | 2019 | |
| Ge Healthcare | $17.62 | 2022 | |
| Immunocore Limited | $14.94 | 2024 | Kimmtrak |
| Emmaus Medical, INC. | $14.71 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.95 | 2021 | |
| Nestle Healthcare Nutrition INC. | $13.51 | 2023 | |
| Secura Bio, INC. | $10.30 | 2020 |
Drugs and devices associated with these payments
Keytruda $667Darzalex $348Enhertu $343Lynparza $320Opdivo $313Libtayo $311Kisqali $239Verzenio $188Jaypirca $182Rezlidhia $179Tavalisse $179Trodelvy $160Imbruvica $156Tecvayli $154Scemblix $150Opdualag $143Vitrakvi $141Stivarga $141Adcetris $138Calquence $135Ibrance $128Lorbrena $127Onivyde $126Padcev $121Brukinsa $114Elrexfio $107Yescarta $104Lenvima $100Xtandi $99.69Beleodaq $99.02Piqray $97.20Vonjo $93.53Cosela $93.52Talvey $92.99Inqovi $91.43Lonsurf $91.43Ojjaara $89.58Braftovi $87.08Imfinzi $86.42Venclexta $83.39Iclusig $82.30Jakafi $82.20Nubeqa $81.57Cabometyx $80.25Somatuline Depot $77.63Doptelet $74.99Ninlaro $73.61Injectafer $73.55Monjuvi $72.62Pomalyst $71.57Sarclisa $71.40Mektovi $70.56Pluvicto $69.63Reblozyl $68.86Fruzaqla $68.12Ultomiris $67.85Tukysa $66.54Epkinly $63.40Lunsumio $63.11Polivy $63.11Clonoseq $62.60Xpovio $59.82Retevmo $58.06Zepzelca $57.93Bosulif $56.42Jevtana $54.82Rybrevant $50.37Orserdu $48.50Balversa $47.63Erleada $47.63Givlaari $46.13Blincyto $44.42Kyprolis $44.42Columvi $43.48Talzenna $42.77Orgovyx $42.77Pemazyre $40.97Promacta $40.89Paxlovid $38.77Comirnaty $38.77Krazati $37.87Inlyta $37.82Fotivda $35.65Gavreto $32.84Zynlonta $32.30Ogsiveo $31.86Akeega $29.94Itovebi $29.50Xospata $26.72Lutathera $26.40Welireg $25.95Fabhalta $25.85Empaveli $25.14Rytelo $24.21Danziten $22.53Alecensa $22.51Rozlytrek $22.51Avastin $22.51Tecentriq $22.51Carvykti $21.79
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Luskey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.